Revenue Growth and Visits Expansion
Total revenue of $198.0M, up 7.9% year-over-year; total patient visits 1.543M, up 6.9% YoY; daily visits per clinic increased to 31.8 from 31.2.
Physical Therapy Performance
Physical therapy revenue $168.0M, up 7.2% YoY; mature (same-store) revenue increased 2.5%, continuing sequential recovery.
Net Patient Revenue per Visit and Payer Mix Benefits
Net patient revenue per visit $106.49 versus $105.66 prior year (increase of ~$0.83); commercial revenue per visit up 3.4% and commercial payers represent nearly 50% of payer mix; early benefit from expected 1.75% Medicare rate increase beginning to flow.
Industrial Injury Prevention (IIP) Momentum
IIP revenue $31.0M, up 11.8% YoY (8.2% ex-acquisition); IIP margin improved to 20.4% from 18.6% (up 180 bps).
Adjusted EBITDA and Guidance Reaffirmation
Adjusted EBITDA of $20.2M in Q1 (increase of $0.7M vs Q1 2025); company reaffirmed full-year 2026 adjusted EBITDA guidance of $102M–$106M and stated Q1 finished on budget.
Strategic M&A and Partner Investments
Completed two significant transactions: 50% interest in an eight-clinic PT practice (~$8M revenue, 60k visits) and 70% interest in an IIP business (~$7M revenue); repurchased noncontrolling interests (~$14M) to reinforce partnerships.
Stronger Financial Flexibility
Closed a five-year $450M credit facility (upsized and improved pricing vs prior facility) providing increased capital capacity to fund growth and return capital.
Operational & Product Initiatives Underway
Rolling out semi-virtual front desk, AI-assisted ambient documentation, expanded cash-based programs (laser, shockwave, dry needling) across top partners, and hospital affiliations (NYU onboarding begun); Workday ERP implementation underway targeting end of 2027.
Improved Workforce Retention
Turnover reduced to below 18%, the lowest level measured by the company, improving staffing stability into busier seasons.